ppat.1006741.g009.tif (170.01 kB)
Immunization with the PRV pUL37 R2 mutant protects against lethal encephalitic infection.
figure
posted on 2017-12-07, 18:59 authored by Alexsia L. Richards, Patricia J. Sollars, Jared D. Pitts, Austin M. Stults, Ekaterina E. Heldwein, Gary E. Pickard, Gregory A. SmithMice were vaccinated intranasally with 5 μl of the PRV R2 mutant (6.4 x 108 PFU/ml). Subsequent wild-type challenge was performed by intranasal inoculation with 5 μl of wild-type PRV (8.8 x 109 PFU/ml) at the indicated day post vaccination. Mice showing no signs of disease were euthanized at 672 hours (28 days) post challenge and are indicated in red. * Mouse was euthanized at 504 hours post challenge due to presentation of tremors and an unusual head lesion, although subsequent histology found no indication of viral encephalitis. ** Mouse was euthanized at 168 hours post challenge due to weight loss.
History
Usage metrics
Categories
Keywords
herpes simplex virus typeaxonal transportHSVgangliaaxonal transport mechanismvaricella zoster virusaxonal transport deficitpUL 37 tegument proteintime-lapse fluorescence microscopyPRVepithelial cell linesintracellular capsid motionherpes simplex virus type 1pUL 37 tegument protein guides alpha-herpesvirustrans-synaptic mapping studies
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC